ArticleJournal of substance abuse treatment2019
Medicaid coverage in substance use disorder treatment after the affordable care act.
Article in Journal of substance abuse treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay in the United States.The Journal of clinical psychiatry · 2026Article
- Medicaid Expansion Boosted Specialty Treatment Episodes For Substance Use Disorder In Expansion States, 2010-22.Health affairs (Project Hope) · 2025Article
- Trends in Drug and Polysubstance-Related Deaths in the State of Texas: County Comparisons.Cureus · 2025Article
- Disparities in Alcohol Treatment Use at the Intersection of Race, Ethnicity, Gender, and Insurance.Substance use & addiction journal · 2025Article
- Telehealth Disparities in Outpatient Substance Use Disorder (SUD) Treatment among Medicaid Beneficiaries during COVID-19.Substance use & misuse · 2025Article
- Early-stage implementation of peer-led interventions for emergency department patients with substance use disorder: Findings from a formative qualitative evaluation.Journal of substance use and addiction treatment · 2024Article
- Changes in legal referrals to specialty substance use disorder treatment from 2015-2019.Health & justice · 2024Article
- Harm Reduction and Treatment Among People at High Risk of Overdose.JAMA network open · 2024Article
- Association of copayments with healthcare utilization and expenditures among Medicaid enrollees with a substance use disorder.Journal of substance use and addiction treatment · 2024Article
- Association of random and observed urine drug screening with long-term retention in opioid treatment programs.Drug and alcohol dependence · 2024Article
- Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment.JAMA health forum · 2023Article
- Gaps and barriers in drug and alcohol treatment following implementation of the affordable care act.Drug and alcohol dependence reports · 2022Article
- Workforce Diversity and disparities in wait time and retention among opioid treatment programs.Substance abuse treatment, prevention, and policy · 2022Article
- Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York.JAMA health forum · 2022Article
- Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.Drug and alcohol dependence reports · 2022Article
- Medicaid expansion and opioid supply policies to address the opioid overdose crisis.Drug and alcohol dependence reports · 2022Article
- Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017.Drug and alcohol dependence reports · 2022Article
- The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States.Drug and alcohol dependence · 2022Article
- Effects of Medicaid expansion on alcohol and opioid treatment admissions in U.S. racial/ethnic groups.Drug and alcohol dependence · 2022Article
- Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.Journal of substance abuse treatment · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The Affordable Care Act (ACA) prompted sweeping changes to Medicaid, including expanding insurance coverage to an estimated 12 million previously uninsured Americans, and imposing new parity requirements on benefits for behavioral health services, including substance use disorder treatment. Yet, limited evidence suggests that these changes have reduced the number of uninsured in substance use disorder treatment, or increased access to substance use disorder treatment overall. This study links data from a nationally-representative study of outpatient substance use disorder treatment programs and a unique national survey of state Medicaid programs to capture changes in insurance coverage among substance use disorder treatment patients after ACA implementation. Medicaid expansion was associated with a 15.7-point increase in the percentage of patients insured by Medicaid in substance use disorder treatment programs and a 13.7-point decrease in the percentage uninsured. Restrictions in state Medicaid benefits and utilization policies were associated with a decreased percentage of Medicaid patients in treatment. Moreover, Medicaid expansion was not associated with a change in the total number of clients served over the study period. Our findings highlight the important role Medicaid has played in increasing insurance coverage for substance use disorder treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.